rs11622887
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs11622887(A;A) |
Make rs11622887(A;C) |
Make rs11622887(C;C) |
Reference | GRCh38 38.1/141 |
Chromosome | 14 |
Position | 95476110 |
Gene | SYNE3 |
is a | snp |
is | mentioned by |
dbSNP | rs11622887 |
dbSNP (classic) | rs11622887 |
ClinGen | rs11622887 |
ebi | rs11622887 |
HLI | rs11622887 |
Exac | rs11622887 |
Gnomad | rs11622887 |
Varsome | rs11622887 |
LitVar | rs11622887 |
Map | rs11622887 |
PheGenI | rs11622887 |
Biobank | rs11622887 |
1000 genomes | rs11622887 |
hgdp | rs11622887 |
ensembl | rs11622887 |
geneview | rs11622887 |
scholar | rs11622887 |
rs11622887 | |
pharmgkb | rs11622887 |
gwascentral | rs11622887 |
openSNP | rs11622887 |
23andMe | rs11622887 |
SNPshot | rs11622887 |
SNPdbe | rs11622887 |
MSV3d | rs11622887 |
GWAS Ctlg | rs11622887 |
GMAF | 0.4867 |
Max Magnitude | 0 |
? | (A;A) (A;C) (C;C) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23478653] |
Trait | Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer |
Title | A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy. |
Risk Allele | |
P-val | 3E-7 |
Odds Ratio | 3.50 [2.20-5.60] |